Bejerano, Jerry A.
HRN: 20-24-12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2023
CEFTAZIDIME 1GM (VIAL)
07/08/2023
07/14/2023
IVT
1g
Q8
Septic Arthritis
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes